Boehringer Ingelheim GmbH - Strategic SWOT Analysis Review

  • ID: 1368025
  • SWOT Analysis
  • 51 pages
  • GlobalData
  • Boehringer Ingelheim GmbH
1 of 5

FEATURED COMPANIES

  • Bristol-Myers Squibb Co
  • Eli Lilly and Co
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • Pfizer Inc
  • Phibro Animal Health Corp
  • MORE
Boehringer Ingelheim GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
Highlights

Boehringer Ingelheim GmbH (Boehringer), a subsidiary of CH Boehringer Sohn AG & Co KG is a pharmaceutical company that conducts research, development, manufacture and sale of pharmaceuticals. It offers a wide range of products including human diseases, animal health care products and biopharmaceuticals. The company’s products are used in the treatment of central nervous system disorders, respiratory diseases, cardiovascular diseases, metabolic disorders, cancer, urological and viral conditions, among others. It operates facilities for manufacture pharmaceuticals, chemical active substances, and medical products. Boehringer operates globally through affiliates and is headquartered in Ingelheim am Rhein, Rheinland-Pfalz, Germany.

Boehringer Ingelheim GmbH Key Recent Developments

Aug 07, 2018: Boehringer forms new alliance to develop gene therapy
Aug 06, 2018: Researchers partner with industry to develop ground-breaking gene therapy for CF
Aug 02, 2018: Boehringer Ingelheim launches the initiative In Reach Africa to address key healthcare infrastructure and access priorities across Africa
Aug 01, 2018: Boehringer Ingelheim achieves modest growth in the first half of 2018
Jul 14, 2018: Boehringer Ingelheim unveils 15 new medicines

Reasons to buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with this detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bristol-Myers Squibb Co
  • Eli Lilly and Co
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • Pfizer Inc
  • Phibro Animal Health Corp
  • MORE
Section 1 - About the Company
  • Boehringer Ingelheim GmbH - Key Facts
  • Boehringer Ingelheim GmbH - Key Employees
  • Boehringer Ingelheim GmbH - Key Employee Biographies
  • Boehringer Ingelheim GmbH - Major Products and Services
  • Boehringer Ingelheim GmbH - History
  • Boehringer Ingelheim GmbH - Company Statement
  • Boehringer Ingelheim GmbH - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Boehringer Ingelheim GmbH - Business Description
  • Business Segment: Animal Health
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Biopharmaceuticals
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Discontinued Operations
  • Performance
  • Business Segment: Human Pharmaceuticals
  • Overview
  • Performance
  • Business Segment: Industrial Customers and Other Sales
  • Overview
  • Performance
  • Geographical Segment: Americas
  • Performance
  • Geographical Segment: Asia/Australia/Africa
  • Performance
  • Geographical Segment: Europe
  • Performance
  • R&D Overview
  • Boehringer Ingelheim GmbH - Corporate Strategy
  • Boehringer Ingelheim GmbH - SWOT Analysis
  • SWOT Analysis - Overview
  • Boehringer Ingelheim GmbH - Strengths
  • Boehringer Ingelheim GmbH - Weaknesses
  • Boehringer Ingelheim GmbH - Opportunities
  • Boehringer Ingelheim GmbH - Threats
  • Boehringer Ingelheim GmbH - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Boehringer Ingelheim GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Boehringer Ingelheim GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Boehringer Ingelheim GmbH, Recent Deals Summary
Section 4 - Company’s Recent Developments
  • Aug 06, 2018: Researchers partner with industry to develop ground-breaking gene therapy for CF
  • Aug 02, 2018: Boehringer Ingelheim launches the initiative In Reach Africa to address key healthcare infrastructure and access priorities across Africa
  • Aug 01, 2018: Boehringer Ingelheim achieves modest growth in the first half of 2018
  • Jul 11, 2018: Boehringer Ingelheim acquires MabVax’s programme for solid tumours
  • Jul 04, 2018: Boehringer Ingelheim extends “one-stop-shop” service with new fill & finish capabilities in China
  • May 23, 2018: Big Pharma CMOs Win for Biologic API and Alcami Scores Highest for Biologic Drug Product
  • Apr 25, 2018: Boehringer Ingelheim has a very successful 2017 financial year
  • Apr 25, 2018: Boehringer Ingelheim RD pushes to transcend disease boundaries
  • Apr 24, 2018: Topas Therapeutics and Boehringer Ingelheim Sign Multi-Year Collaboration and Option Agreement
  • Apr 11, 2018: Investment Of 65 Million Euro In Avian Vaccines In France
Section 5 - Appendix
  • Methodology
  • About
  • Contact
  • Disclaimer
List of Tables
  • Boehringer Ingelheim GmbH, Key Facts
  • Boehringer Ingelheim GmbH, Key Employees
  • Boehringer Ingelheim GmbH, Key Employee Biographies
  • Boehringer Ingelheim GmbH, Major Products and Services
  • Boehringer Ingelheim GmbH, History
  • Boehringer Ingelheim GmbH, Other Locations
  • Boehringer Ingelheim GmbH, Subsidiaries
  • Boehringer Ingelheim GmbH, Key Competitors
  • Boehringer Ingelheim GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Boehringer Ingelheim GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Boehringer Ingelheim GmbH, Recent Deals Summary
List of Figures
  • Boehringer Ingelheim GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Boehringer Ingelheim GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Bristol-Myers Squibb Co
  • Eli Lilly and Co
  • F. Hoffmann-La Roche Ltd
  • Jurgen Schmidt Chemievertretung GmbH
  • Novartis AG
  • Pfizer Inc
  • Phibro Animal Health Corp
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll